Prevalence and evolution of clinical cases of Yellow Fever in Brazil between the years 2007 to 2016
DOI:
https://doi.org/10.33448/rsd-v11i1.24852Keywords:
Yellow Fever; Prevalence; Clinical evolution.Abstract
Yellow Fever (YF) is a non-contagious infectious disease of variable symptoms that occurs mainly in tropical forests regions of the Americas and Africa and is caused by a Flavivirus belonging to the Flaviviridae family. Its vectors are mosquitoes of the genus Haemagogus, Sabethes and Aedes, and these have non-human primates as the main source of infection. In Brazil, there has been no record of urban AF since 1942, although the increase in cases of the wild form combined with low vaccination coverage contribute to the risk of re-urbanization of the disease Material and methods: For the study, epidemiological data were obtained from confirmed cases of Yellow Fever reported in the Notification System for Health Disorders (SINAN) available at the Informatics Department of the Unified Health System (DATASUS). Results and discussion: A total of 177 cases of were reported in Brazil, the year with the highest notification was in 2016 (52). The region with the highest occurrence of cases were the Southeast (95). Regarding the clinical evolution, of the 177 cases, 68 affected patients were cured, while 89 died from the reported injury, evidencing a high rate of lethality (50.2%). Conclusion: YF remains a public health problem, over the years there was a decrease in cases, this was due to immunization campaigns in the country, however, there was a significant increase in notifications in 2016, this whole panorama reinforces the need intensifying surveillance and expanding vaccine coverage.
References
Bacha, H. A., & Johanson, G. H. (2017). Yellow fever. Revista da Associação Médica Brasileira, 63(4), 291-292.
Barrett, A. D., & Monath, T. P. (2003). Epidemiology and ecology of yellow fever virus. Advances in virus research, 61, 291-317.
Beasley, D. W., McAuley, A. J., & Bente, D. A. (2015). Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy. Antiviral research, 115, 48-70.
Bolanho, C. A., & Santos, C. A. C. D. (2017). Perfil epidemiológico dos casos de febre amarela no Brasil no período de 2007-2017.
Cavalcante, K. R. L. J., & Tauil, P. L. (2016). Características epidemiológicas da febre amarela no Brasil, 2000-2012. Epidemiologia e Serviços de Saúde, 25, 11-20.
Cavalcante, K. R. L. J., & Tauil, P. L. (2017). Risco de reintrodução da febre amarela urbana no Brasil. Epidemiologia e Serviços de Saúde, 26, 617-620.
Casali, F. T., Minucci, G. S., Meira, A. L. P., & Souza, L. P. S. (2019). Análise das características epidemiológicas da febre amarela em um estado da Região Sudeste do Brasil. Enfermería Actual de Costa Rica, (37), 50-65.
Fantini, D. C., Alves, V., Pastor, M. V. D. Á., Geraldo, A., & Bueno, E. C. (2021). Perfil epidemiológico da febre amarela da região Sul do Brasil, de 2007 a 2019. Brazilian Journal of Health Review, 4(1), 891-907.
Ho, Y. L., Joelsons, D., Leite, G. F., Malbouisson, L. M., Song, A. T., Perondi, B., ... & Hospital das Clínicas Yellow Fever Assistance Group. (2019). Severe yellow fever in Brazil: clinical characteristics and management. Journal of travel medicine, 26(5), taz040.
Ishak, R., de Oliveira Guimarães Ishak, M., Vallinoto, A. C. R., & De Paula Pinheiro, F. (2020). Yellow fever virus: historical and current issues regarding recent epidemics and vaccination in Brazil. Human vaccines & immunotherapeutics, 16(4), 900-903.
Jentes, E. S., Poumerol, G., Gershman, M. D., Hill, D. R., Lemarchand, J., Lewis, R. F., ... & Monath, T. P. (2011). The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. The Lancet infectious diseases, 11(8), 622-632.
Leite, A. A., & Errante, P. R. (2017). Aspectos clínicos, prevenção e epidemiologia da Febre Amarela no Brasil. UNILUS Ensino e Pesquisa, 14(34), 169-184.
Litvoc, M. N., Novaes, C. T. G., & Lopes, M. I. B. F. (2018). Yellow fever. Revista da Associação Médica Brasileira, 64, 106-113..
Lopes, R. L., Pinto, J. R., Silva, G. B. D., Santos, A. K. T., Souza, M. T. O., & Daher, E. D. F. (2019). Kidney involvement in yellow fever: a review. Revista do Instituto de Medicina Tropical de São Paulo, 61.
Mascheretti, M., Tengan, C. H., Sato, H. K., Suzuki, A., Souza, R. P. D., Maeda, M., ... & Ribeiro, A. F. (2013). Febre amarela silvestre: reemergência de transmissão no estado de São Paulo, Brasil, 2009. Revista de Saúde Pública, 47, 881-889.
Monath, T. P., & Vasconcelos, P. F. (2015). Yellow fever. Journal of clinical virology, 64, 160-173.
Noronha, T. G. D., & Camacho, L. A. B. (2017). Controvérsias sobre a ampliação das áreas com vacinação de rotina contra a febre amarela no Brasil. Cadernos de Saúde Pública, 33, e00060917.
Rollins, D., Ramsey, R., & Parsh, B. (2017). Yellow fever. Nursing2020, 47(9), 69-70.
Vieira, Y. P., Petry, L., dos Santos, L. E., Soder, R. M., de Marco, V. R., de Souza Quevedo, P., ... & da Silva, L. A. A. (2020). Descrição epidemiológica da febre amarela no brasil: alerta sobre a expansão da doença. Brazilian Journal of Health Review, 3(5), 13383-13395.
Waggoner, J. J., Rojas, A., & Pinsky, B. A. (2018). Yellow fever virus: diagnostics for a persistent arboviral threat. Journal of clinical microbiology, 56(10), e00827-18.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Caroline Ferreira Fernandes; Juliana Hiromi Emin Uesugi; Jonatan Carlos Cardoso da Silva; Hadassa Hanna Soares Martins; Bruna Raciele de Sousa Nascimento; Eliane Leite da Trindade; Lucas Araújo Ferreira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.